We could not find any results for:
Make sure your spelling is correct or try broadening your search.
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases. MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.
MoonLake Immunotherapeutics starts Phase 3 VELA program of the Nanobody® sonelokimab in patients with moderate-to-severe hidradenitis suppurativa VELA is the first Phase 3 program in hidradenitis...
MoonLake Immunotherapeutics Reports First Quarter 2024 Financial Results and Provides a Business Update Announced positive feedback from both FDA and EMA on the regulatory path for the Phase 3...
MoonLake To Tap Into Komodo’s Technology and Real-World Data To Unlock the Full Potential of Its Next-Gen Nanobody® Therapy MoonLake Immunotherapeutics (“MoonLake”; Nasdaq: MLTX), a...
MoonLake announces significant improvements with Nanobody® sonelokimab over 24 weeks in active psoriatic arthritis (PsA) and other important updates at its R&D Day Positive 24-week data...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 3.16 | 8.1992734821 | 38.54 | 42 | 38.54 | 357968 | 39.97832259 | CS |
4 | 0.45 | 1.09090909091 | 41.25 | 45.56 | 37.83 | 308619 | 41.25672408 | CS |
12 | -7.16 | -14.6541137945 | 48.86 | 53.99 | 37.83 | 405067 | 45.36481578 | CS |
26 | -3.4 | -7.53880266075 | 45.1 | 64.98 | 37.83 | 464949 | 51.05895962 | CS |
52 | 13.54 | 48.0823863636 | 28.16 | 64.98 | 24.31 | 583762 | 49.79106313 | CS |
156 | 29.33 | 237.105901374 | 12.37 | 64.98 | 4.25 | 355153 | 41.94048118 | CS |
260 | 29.33 | 237.105901374 | 12.37 | 64.98 | 4.25 | 355153 | 41.94048118 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions